1919

OBSTRUKTİF UYKU APNE SENDROMU’NDA NÖTROFİL LENFOSİT ORANI

Amaç: Nötrofil ve lenfosit oranı (NLO)’nın inflamatuar belirteç olarak inflamatuar hastalıklarda rolü keşfe-dilmiştir. Obstruktif uyku apne sendromu (OSAS)’da komorbiditeler ile OSAS’da artan NLO arasındaki ilişkideğerlendirildi.Yöntem: Toplam 232 OSAS hastası çalışmaya alındı. 50 OSAS olmayan olgu kontrol grubunu oluşturdu. NLOher hasta ve kontrol olgusu için hesaplandı ve kaydedildi. Nötrofil lenfosit oranıyla hipertansiyon arasındakiilişki hipertansiyonu olan ve olmayan iki alt hasta grubunda değerlendirildi.Bulgular: Çalışmada 100 kadın (%43.1), 132 erkek (%56.9) hasta mevcuttu. OSAS hastalarında ortalama NLO(1.76±0.77), kontrol grubunda ortalama NLO (1.31±0.74) ile karşılaştırıldığında anlamlı olarak daha yüksekti(p= 0.000). Hipertansiyon (HT) olan (3.59±14.92) ve olmayan (1.72±0.69) OSAS’lı hastalarda NLO’da anlamlıfarklılık saptandı (p= 0.014).Sonuç: OSAS’da NLO inflamatuar belirteç olarak değerli olabilir. OSAS’da artan NLO, bu hastalardaki HT gibikomorbid durumlardan kaynaklanabilir. Bu ucuz ve pratik method, günlük klinik pratikte, OSAS hastalarındakomorbiditeyi öngörmek için kullanılabilir.

Neutrophil To Lymphocyte Ratio In Obstructive Sleep Apnea Syndrome

Objective: The role of neutrophil to lymphocyte ratio as an inflammatory marker in inflammatory conditions has been explored. The association between neutrophil to lymphocyte ratio, which is elevated in patients with obstructive sleep apnea syndrome, and hypertension in obstructive sleep apnea syndrome has been examined. Methods: A total of 232 obstructive sleep apnea syndrome patients were included in this study. A total of 50 subjects without obstructive sleep apnea syndrome comprised the control group. The neutrophil to lymphocyte ratio was calculated and recorded for each patient and control subject. The association of neutrophil to lymphocyte ratio to hypertension was investigated in two sub-groups of patients defined on the basis of the presence or absence of hypertension. Results: There were 100 (43.1%) female and 132 (56.9%) male patients in the study. Obstructive sleep apnea syndrome patients had significantly higher average neutrophil to lymphocyte ratio (1.76 ± 0.77) as compared to controls (1.31 ± 0.74) (p=0.000). A significant difference in neutrophil to lymphocyte ratio between obstructive sleep apnea syndrome patients with (3.59 ± 14.92) or without (1.72 ± 0.69) hypertension was found (p=0.014). Conclusion: Neutrophil to lymphocyte ratio may find some value as an inflammatory marker in obstructive sleep apnea syndrome. Elevated neutrophil to lymphocyte ratio in obstructive sleep apnea syndrome may arise from comorbid conditions such as hypertension in these patients. This cheap and practical method may be used in daily clinical practice to predict comorbidity in OSAS patients.

PDF

___

Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E. Correlates of serum C-reactive protein (CRP)-no association with sleep duration or sleep disordered breathing. Sleep 2007;30:991-6.
El-Solh AA, Mador MJ, Sikka P, Dhillon RS, Amsterdam D, Grant BJ. Adhesion molecules in patients with coronary artery dis- ease and moderate – to severe obstructive sleep apnea. Chest 2002;121:1541-7.
Nural S, Günay E, Halici B, Celik S, Ünlü M. Inflammatory pro- cesses and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 2013;36:66-74.
Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-kappa B-dependent genes in obstructive sleep apnea syn- drome. Am J Respir Crit Care Med 2006;174:824-30.
Korkmaz M, Korkmaz H, Küçüker F, Ayyıldız SN, Çankaya S. Evalua- tion of the Association of Sleep Apnea- Related Systemic Inflamma- tion with CRP, ESR, and Neutrophil-to-Lymphocyte Ratio. Med Sci Monit 2015;21:477-481.
Faraut B, Boudjeltia KZ, Vanhamme L, Kerkhofs M. Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev 2012;16(2):137–49.
Khan F, Walsh C, Lane SJ, Moloney E. Sleep apnoea and its relationship with cardiovascular, pulmonary, metabolic and other morbidities. Ir Med J 2014; 107(1): 6-8.
Sawant AC, Adhikari P, Narra SR, Srivatsa SS, Mills PK, Srivatsa SS. Neutrophil to lymphocyte ratio pre¬dicts short and long term mortality following revascularization therapy for ST elevation myo- cardial infarction. Cardiol J 2014;21:500–8
Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil- lymphocyte ratio as a prog-nostic factor in colorectal cancer. J Surg Oncol 2005;91:181–84
Panoutsopoulos A, Kallianos A, Kostopoulos K, Seretis C, Koufogiorga E, Protogerou A, et al. Effect of CPAP treat¬ment on endothelial function and plasma CRP levels in patients with sleep apnea. Med Sci Monit 2012; 18: 747–51.
Young T, Peppard P. Sleep-disordered breathing and cardiovascular disease: epidemiologic evidence for a relationship. Sleep 2000; 23: 122-126.
Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, et al. Sleep-disordered breathing and cardiovascular disease: cross- sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.
Cano-Pumarega I, Durán-Cantolla J, Aizpuru F, Miranda-Serrano E, Rubio R, Martínez C, et al. Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: the Vitoria Sleep Cohort. Am J Respir Crit Care Med 2011; 184: 1299- 1304.
Destors M, Tamisier R, Baguet JP, Levy P, Pepin JL. Cardiovascu- lar morbidity associated with obstructive sleep apnea syndrome. Rev Mal Respir 2014; 31(4): 375-85.
Balta S, Ozturk C, Yildirim AO, Aparci M, Demir M, Celik T. The Relation Between Neutrophil-Lymphocyte Ratio and Hypertension. Am J Hypertens 2015; 28: 1386.
Liu X, Zhang Q, Wu H, Du H, Liu L, Shi H, et al. Blood Neutrophil to Lymphocyte Ratio as a Predictor of Hypertension. Am J Hyper- tens 2015; 28: 1339-46.